Verrica Pharmaceuticals VRCA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 4.31 | -17 | 0 | -0.68 | 41 | |
| 2025Q2 | 5.30 | -17 | 0 | 0.50 | 39 | |
| 2025Q1 | 4.42 | -19 | -10 | -20.23 | 42 | |
| 2024Q4 | 7.00 | -10 | -16 | -37.22 | 54 | |
| 2024Q3 | 14.50 | -34 | -23 | -53.83 | 33 | |
| 2024Q2 | 72.90 | -13 | -17 | -29.05 | 52 | |
| 2024Q1 | 59.20 | 2 | -191.16 | -20 | -27.49 | 66 |
| 2023Q4 | 73.20 | 20 | -79.32 | -25 | -27.54 | 82 |
| 2023Q3 | 38.85 | 42 | -50.77 | -25 | -31.13 | 97 |
| 2023Q2 | 57.70 | 55 | -18.28 | -11 | -16.80 | 62 |
| 2023Q1 | 65.00 | 65 | -12.56 | -7 | -11.62 | 69 |
| 2022Q4 | 27.50 | 40 | -13.99 | -6 | -12.64 | 45 |
| 2022Q3 | 29.20 | 45 | 0.27 | 0 | 0.15 | 49 |
| 2022Q2 | 19.20 | 16 | -48.71 | -10 | -15.06 | 63 |
| 2022Q1 | 81.10 | 25 | -29.20 | -8 | -11.16 | 72 |
| 2021Q4 | 91.60 | 33 | -25.97 | -10 | -11.30 | 80 |
| 2021Q3 | 125.00 | 41 | -27.59 | -13 | -13.66 | 89 |
| 2021Q2 | 113.00 | 52 | -20.66 | -12 | -11.37 | 99 |
| 2021Q1 | 151.50 | 62 | -1.97 | -1 | -1.03 | 108 |
| 2020Q4 | 115.10 | 33 | -35.96 | -13 | -16.84 | 74 |